References analysis of the Wikipedia article "Imiquimod" in the English version

cancer.gov

"FDA Approval for Imiquimod". U.S. Food And Drug Administration. 1 January 2011. Archived from the original on 6 April 2015. Retrieved 19 October 2012. Imiquimod should be used for treatment of [superficial basal cell carcinoma] only when surgery is medically less appropriate

"NCI: FDA Approval for Imiquimod". National Cancer Institute. 3 July 2013. Archived from the original on 23 January 2018.

doi.org

Schön MP, Schön M (December 2007). "Imiquimod: mode of action". The British Journal of Dermatology. 157 (Suppl 2): 8–13. doi:10.1111/j.1365-2133.2007.08265.x. PMID 18067624. S2CID 36643157.

Walter A, Schäfer M, Cecconi V, Matter C, Urosevic-Maiwald M, Belloni B, et al. (2013). "Aldara activates TLR7-independent immune defence". Nature Communications. 4: 1560. Bibcode:2013NatCo...4.1560W. doi:10.1038/ncomms2566. PMID 23463003.

Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, et al. (February 2002). "Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway". Nature Immunology. 3 (2): 196–200. doi:10.1038/ni758. PMID 11812998. S2CID 1694900.

Bilu D, Sauder DN (November 2003). "Imiquimod: modes of action". The British Journal of Dermatology. 149 (Suppl 66): 5–8. doi:10.1046/j.0366-077x.2003.05628.x. PMID 14616337. S2CID 41274637.

Miller RL, Gerster JF, Owens ML, Slade HB, Tomai MA (January 1999). "Imiquimod applied topically: a novel immune response modifier and new class of drug". International Journal of Immunopharmacology. 21 (1): 1–14. doi:10.1016/s0192-0561(98)00068-x. PMID 10411278.

Zagon IS, Donahue RN, Rogosnitzky M, McLaughlin PJ (August 2008). "Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function". Experimental Biology and Medicine. 233 (8): 968–979. doi:10.3181/0802-RM-58. PMID 18480416. S2CID 35164284.

Bayerl C, Feller G, Goerdt S (November 2003). "Experience in treating molluscum contagiosum in children with imiquimod 5% cream". The British Journal of Dermatology. 149 (Suppl 66): 25–29. doi:10.1046/j.0366-077x.2003.05631.x. PMID 14616342. S2CID 23728783.

Arican O (August 2006). "Topical treatment of molluscum contagiosum with imiquimod 5% cream in Turkish children". Pediatrics International. 48 (4): 403–405. doi:10.1111/j.1442-200X.2006.02229.x. PMID 16911087. S2CID 2867793.

van Seters M, van Beurden M, ten Kate FJ, Beckmann I, Ewing PC, Eijkemans MJ, et al. (April 2008). "Treatment of vulvar intraepithelial neoplasia with topical imiquimod". The New England Journal of Medicine. 358 (14): 1465–1473. doi:10.1056/NEJMoa072685. PMID 18385498.

Buck HW, Guth KJ (October 2003). "Treatment of vaginal intraepithelial neoplasia (primarily low grade) with imiquimod 5% cream". Journal of Lower Genital Tract Disease. 7 (4): 290–293. doi:10.1097/00128360-200310000-00011. PMID 17051086. S2CID 44649376.

Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R (September 2012). "Topical treatments for cutaneous warts". The Cochrane Database of Systematic Reviews. 2012 (9): CD001781. doi:10.1002/14651858.CD001781.pub3. PMC 8101088. PMID 22972052.

Harwood CA, Perrett CM, Brown VL, Leigh IM, McGregor JM, Proby CM (January 2005). "Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals". The British Journal of Dermatology. 152 (1): 122–129. doi:10.1111/j.1365-2133.2005.06322.x. PMID 15656812. S2CID 42369353.

Ahn CS, Huang WW (October 2014). "Imiquimod in the treatment of cutaneous warts: an evidence-based review". American Journal of Clinical Dermatology. 15 (5): 387–399. doi:10.1007/s40257-014-0093-5. PMID 25186654. S2CID 26624740.

drugs.com

europa.eu

ema.europa.eu

European Medicines Agency. First published 14 September 2009, updated 25 March 2015. EMA Summary of Product Characteristics Archived 25 September 2017 at the Wayback Machine

"Aldara EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 14 July 2020. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

"Zyclara EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 14 July 2020. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

nih.gov

pubmed.ncbi.nlm.nih.gov

Schön MP, Schön M (December 2007). "Imiquimod: mode of action". The British Journal of Dermatology. 157 (Suppl 2): 8–13. doi:10.1111/j.1365-2133.2007.08265.x. PMID 18067624. S2CID 36643157.

Bilu D, Sauder DN (November 2003). "Imiquimod: modes of action". The British Journal of Dermatology. 149 (Suppl 66): 5–8. doi:10.1046/j.0366-077x.2003.05628.x. PMID 14616337. S2CID 41274637.

Theos AU, Cummins R, Silverberg NB, Paller AS (August 2004). "Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial". Cutis. 74 (2): 134–8, 141–2. PMID 15379366.

dailymed.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

Schön MP, Schön M (December 2007). "Imiquimod: mode of action". The British Journal of Dermatology. 157 (Suppl 2): 8–13. doi:10.1111/j.1365-2133.2007.08265.x. PMID 18067624. S2CID 36643157.

Bilu D, Sauder DN (November 2003). "Imiquimod: modes of action". The British Journal of Dermatology. 149 (Suppl 66): 5–8. doi:10.1046/j.0366-077x.2003.05628.x. PMID 14616337. S2CID 41274637.

web.archive.org

"The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.

"Imiquimod Cream". Guide To Cancer Drugs. American Cancer Society. Archived from the original on 7 February 2015. Retrieved 28 April 2014.

European Medicines Agency. First published 14 September 2009, updated 25 March 2015. EMA Summary of Product Characteristics Archived 25 September 2017 at the Wayback Machine

"NCI: FDA Approval for Imiquimod". National Cancer Institute. 3 July 2013. Archived from the original on 23 January 2018.

"Press release: 3M Reaches Agreements to Sell its Pharmaceuticals Business]". 3M. 9 November 2006. Archived from the original on 21 August 2019.

"Aldara (imiquimod) cream for topical use. Prescribing information". Archived from the original on 2 November 2013.

Imiquimod (English Wikipedia)

3m.com

news.3m.com

bizjournals.com

cancer.gov

cancer.org

centerwatch.com

clincalc.com

clinicaltrials.gov

doi.org

dpic.org

drugs.com

europa.eu

ema.europa.eu

fda.gov

nctr-crs.fda.gov

harvard.edu

ui.adsabs.harvard.edu

medlineplus.gov

medscape.com

emedicine.medscape.com

nih.gov

pubmed.ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

ncbi.nlm.nih.gov

pdr.net

semanticscholar.org

api.semanticscholar.org

web.archive.org